{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Kirkland",
      "state": "WA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97292",
      "recalling_firm": "AEQUITA PHARMACY",
      "address_1": "12825 Ne 126th Pl",
      "address_2": "N/A",
      "postal_code": "98034-7721",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "MA",
      "recall_number": "D-0559-2025",
      "product_description": "Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.",
      "product_quantity": "143 vials",
      "reason_for_recall": "Lack of Processing Controls.",
      "recall_initiation_date": "20250718",
      "center_classification_date": "20250801",
      "report_date": "20250813",
      "code_info": "All Lots within expiry.",
      "more_code_info": ""
    }
  ]
}